反応 #1340615
ord-3cff4d257ba44f09b487fd7399a1b7b8
反応方程式
反応物
試薬
反応条件
後処理
- 1その他was removed under reduced pressure
- 2workup.ADDITIONSubsequently, 1 mol/L hydrochloric acid was added
- 3抽出followed by extraction with ethyl acetate (100 mL×3)
- 4洗浄The ethyl acetate layer was washed by saturated brine (100 mL)
- 5乾燥dried over anhydrous sodium sulfate
- 6ろ過After filtration
- 7濃縮the filtrate was concentrated under reduced pressure
- 8workup.DISSOLUTIONThe obtained residue was dissolved in concentrated hydrochloric acid (5 mL)
- 9洗浄the solution was washed by chloroform (50 mL)
- 10抽出followed by extraction with chloroform (100 mL×3)
- 11乾燥drying over anhydrous sodium sulfate
- 12ろ過After filtration
- 13濃縮the filtrate was concentrated under reduced pressure
- 14その他the obtained residue was recrystallized from ethanol
実験手順
A 1 mol/L aqueous sodium hydroxide solution (5 mL, 5 mmol) was added under cooling with ice to ethyl 7-[(3S,4S)-3-(tert-butoxycarbonyl)amino-4-methylpyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate (957 mg, 1.96 mmol) in ethanol (10 mL), and the mixture was stirred at room temperature for 3 hours. The resultant mixture was neutralized with 1 mol/L hydrochloric acid under cooling with ice, and ethanol was removed under reduced pressure. Subsequently, 1 mol/L hydrochloric acid was added thereto, followed by extraction with ethyl acetate (100 mL×3). The ethyl acetate layer was washed by saturated brine (100 mL), and dried over anhydrous sodium sulfate. After filtration, the filtrate was concentrated under reduced pressure. The obtained residue was dissolved in concentrated hydrochloric acid (5 mL), and the solution was washed by chloroform (50 mL). The pH of the resultant mixture was adjusted to 7.8 with an aqueous sodium hydroxide solution, followed by extraction with chloroform (100 mL×3) and drying over anhydrous sodium sulfate. After filtration, the filtrate was concentrated under reduced pressure, and the obtained residue was recrystallized from ethanol, to thereby yield the title compound as pale yellow crystals (420 mg, 58.2%).